Lipid Management in Clinical Practice (MK-0524A-115)
NCT01071278 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2390
Last updated 2015-08-11
Summary
The aim of this observational program is to generate data on the use of Tredaptive (nicotinic acid/laropiprant) for lipid management under routine medical practice conditions.
Conditions
- Lipid Metabolism Disorder
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Monitor · Merck Sharp & Dohme LLC
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2011-02-28
- Completion
- 2011-02-28
More Related Trials
-
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
NCT01594983 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels
NCT00813527 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia
NCT00504829 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)
NCT01335997 ·Status: TERMINATED ·Phase: PHASE3
-
Investigating the Effect of Obicetrapib on Lipoprotein Metabolism
NCT05972278 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
NCT00134238 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.
NCT00256178 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies
NCT05142722 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)
NCT01294683 ·Status: TERMINATED ·Phase: PHASE3
-
Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes
NCT01265836 ·Status: WITHDRAWN
-
Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
NCT01974297 ·Status: UNKNOWN ·Phase: NA
-
Randomized Study of Obicetrapib in Combination With Ezetimibe
NCT04770389 ·Status: COMPLETED ·Phase: PHASE2
-
Atlantic Lipid Lowering Treatment Optimization Program
NCT06439654 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia
NCT07034690 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia
NCT00487994 ·Status: COMPLETED ·Phase: PHASE3
-
Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy
NCT00079859 ·Status: TERMINATED ·Phase: PHASE2
-
Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia
NCT00134485 ·Status: COMPLETED ·Phase: PHASE3
-
Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.
NCT00136981 ·Status: COMPLETED ·Phase: PHASE3
-
Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)
NCT00935259 ·Status: COMPLETED ·Phase: PHASE1
-
Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin
NCT01785615 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides
NCT00134498 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004)
NCT00847197 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects
NCT02681055 ·Status: COMPLETED ·Phase: PHASE2
-
National Survey on Dyslipidemic Patients
NCT00701402 ·Status: COMPLETED
-
Lipid-lowering Therapy Individualization
NCT03604471 ·Status: COMPLETED ·Phase: PHASE4